Long-Term Results of Mitral Valve Repair
Main Author: | |
---|---|
Publication Date: | 2018 |
Other Authors: | , , , , , , , , |
Format: | Article |
Language: | eng |
Source: | Brazilian Journal of Cardiovascular Surgery (Online) |
Download full: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000100023 |
Summary: | Abstract Introduction: Current guidelines state that patients with severe mitral regurgitation should be treated in reference centers with a high reparability rate, low mortality rate, and durable results. Objective: To analyze our global experience with the treatment of organic mitral regurgitation from various etiologies operated in a single center. Methods: We evaluated all surgically treated patients with organic mitral regurgitation from 2004-2017. Patients were evaluated clinically and by echocardiography every year. We determined early and late survival rates, valve related events and freedom from recurrent mitral regurgitation and tricuspid regurgitation. Valve failure was defined as any mitral regurgitation ≥ moderate degree or the need for reoperation for any reason. Results: Out of 133 patients with organic mitral regurgitation, 125 (93.9%) were submitted to valve repair. Mean age was 57±15 years and 52 patients were males. The most common etiologies were degenerative disease (73 patients) and rheumatic disease (34 patients). Early mortality was 2.4% and late survival was 84.3% at 10 years, which are similar to the age- and gender-matched general population. Only two patients developed severe mitral regurgitation, and both were reoperated (95.6% at 10 years). Freedom from mitral valve failure was 84.5% at 10 years, with no difference between degenerative and rheumatic valves. Overall, late ≥ moderate tricuspid regurgitation was present in 34% of the patients, being more common in the rheumatic ones. The use of tricuspid annuloplasty abolished this complication. Conclusion: We have demonstrated that mitral regurgitation due to organic mitral valve disease from various etiologies can be surgically treated with a high repair rate, low early mortality and long-term survival that are comparable to the matched general population. Concomitant treatment of atrial fibrillation and tricuspid valve may be important adjuncts to optimize long-term results. |
id |
SBCCV-1_5fc6026e4091e464c571e42e1d988555 |
---|---|
oai_identifier_str |
oai:scielo:S0102-76382018000100023 |
network_acronym_str |
SBCCV-1 |
network_name_str |
Brazilian Journal of Cardiovascular Surgery (Online) |
repository_id_str |
|
spelling |
Long-Term Results of Mitral Valve RepairMitral ValveMitral Valve InsufficiencyMitral Valve ProlapseMitral Valve AnnuloplastyAbstract Introduction: Current guidelines state that patients with severe mitral regurgitation should be treated in reference centers with a high reparability rate, low mortality rate, and durable results. Objective: To analyze our global experience with the treatment of organic mitral regurgitation from various etiologies operated in a single center. Methods: We evaluated all surgically treated patients with organic mitral regurgitation from 2004-2017. Patients were evaluated clinically and by echocardiography every year. We determined early and late survival rates, valve related events and freedom from recurrent mitral regurgitation and tricuspid regurgitation. Valve failure was defined as any mitral regurgitation ≥ moderate degree or the need for reoperation for any reason. Results: Out of 133 patients with organic mitral regurgitation, 125 (93.9%) were submitted to valve repair. Mean age was 57±15 years and 52 patients were males. The most common etiologies were degenerative disease (73 patients) and rheumatic disease (34 patients). Early mortality was 2.4% and late survival was 84.3% at 10 years, which are similar to the age- and gender-matched general population. Only two patients developed severe mitral regurgitation, and both were reoperated (95.6% at 10 years). Freedom from mitral valve failure was 84.5% at 10 years, with no difference between degenerative and rheumatic valves. Overall, late ≥ moderate tricuspid regurgitation was present in 34% of the patients, being more common in the rheumatic ones. The use of tricuspid annuloplasty abolished this complication. Conclusion: We have demonstrated that mitral regurgitation due to organic mitral valve disease from various etiologies can be surgically treated with a high repair rate, low early mortality and long-term survival that are comparable to the matched general population. Concomitant treatment of atrial fibrillation and tricuspid valve may be important adjuncts to optimize long-term results.Sociedade Brasileira de Cirurgia Cardiovascular2018-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000100023Brazilian Journal of Cardiovascular Surgery v.33 n.1 2018reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.21470/1678-9741-2017-0145info:eu-repo/semantics/openAccessCosta,Francisco Diniz Affonso daColatusso,Daniele de Fátima FornazariMartin,Gustavo Luis do SantosParra,Kallyne Carolina SilvaBotta,Mariana CozerBalbi Filho,Eduardo MendelVeloso,MyrianMiotto,GabrielaFerreira,Andreia Dumsch de AragonColatusso,Claudineieng2018-03-27T00:00:00Zoai:scielo:S0102-76382018000100023Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2018-03-27T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false |
dc.title.none.fl_str_mv |
Long-Term Results of Mitral Valve Repair |
title |
Long-Term Results of Mitral Valve Repair |
spellingShingle |
Long-Term Results of Mitral Valve Repair Costa,Francisco Diniz Affonso da Mitral Valve Mitral Valve Insufficiency Mitral Valve Prolapse Mitral Valve Annuloplasty |
title_short |
Long-Term Results of Mitral Valve Repair |
title_full |
Long-Term Results of Mitral Valve Repair |
title_fullStr |
Long-Term Results of Mitral Valve Repair |
title_full_unstemmed |
Long-Term Results of Mitral Valve Repair |
title_sort |
Long-Term Results of Mitral Valve Repair |
author |
Costa,Francisco Diniz Affonso da |
author_facet |
Costa,Francisco Diniz Affonso da Colatusso,Daniele de Fátima Fornazari Martin,Gustavo Luis do Santos Parra,Kallyne Carolina Silva Botta,Mariana Cozer Balbi Filho,Eduardo Mendel Veloso,Myrian Miotto,Gabriela Ferreira,Andreia Dumsch de Aragon Colatusso,Claudinei |
author_role |
author |
author2 |
Colatusso,Daniele de Fátima Fornazari Martin,Gustavo Luis do Santos Parra,Kallyne Carolina Silva Botta,Mariana Cozer Balbi Filho,Eduardo Mendel Veloso,Myrian Miotto,Gabriela Ferreira,Andreia Dumsch de Aragon Colatusso,Claudinei |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Costa,Francisco Diniz Affonso da Colatusso,Daniele de Fátima Fornazari Martin,Gustavo Luis do Santos Parra,Kallyne Carolina Silva Botta,Mariana Cozer Balbi Filho,Eduardo Mendel Veloso,Myrian Miotto,Gabriela Ferreira,Andreia Dumsch de Aragon Colatusso,Claudinei |
dc.subject.por.fl_str_mv |
Mitral Valve Mitral Valve Insufficiency Mitral Valve Prolapse Mitral Valve Annuloplasty |
topic |
Mitral Valve Mitral Valve Insufficiency Mitral Valve Prolapse Mitral Valve Annuloplasty |
description |
Abstract Introduction: Current guidelines state that patients with severe mitral regurgitation should be treated in reference centers with a high reparability rate, low mortality rate, and durable results. Objective: To analyze our global experience with the treatment of organic mitral regurgitation from various etiologies operated in a single center. Methods: We evaluated all surgically treated patients with organic mitral regurgitation from 2004-2017. Patients were evaluated clinically and by echocardiography every year. We determined early and late survival rates, valve related events and freedom from recurrent mitral regurgitation and tricuspid regurgitation. Valve failure was defined as any mitral regurgitation ≥ moderate degree or the need for reoperation for any reason. Results: Out of 133 patients with organic mitral regurgitation, 125 (93.9%) were submitted to valve repair. Mean age was 57±15 years and 52 patients were males. The most common etiologies were degenerative disease (73 patients) and rheumatic disease (34 patients). Early mortality was 2.4% and late survival was 84.3% at 10 years, which are similar to the age- and gender-matched general population. Only two patients developed severe mitral regurgitation, and both were reoperated (95.6% at 10 years). Freedom from mitral valve failure was 84.5% at 10 years, with no difference between degenerative and rheumatic valves. Overall, late ≥ moderate tricuspid regurgitation was present in 34% of the patients, being more common in the rheumatic ones. The use of tricuspid annuloplasty abolished this complication. Conclusion: We have demonstrated that mitral regurgitation due to organic mitral valve disease from various etiologies can be surgically treated with a high repair rate, low early mortality and long-term survival that are comparable to the matched general population. Concomitant treatment of atrial fibrillation and tricuspid valve may be important adjuncts to optimize long-term results. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000100023 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382018000100023 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.21470/1678-9741-2017-0145 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cirurgia Cardiovascular |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cirurgia Cardiovascular |
dc.source.none.fl_str_mv |
Brazilian Journal of Cardiovascular Surgery v.33 n.1 2018 reponame:Brazilian Journal of Cardiovascular Surgery (Online) instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV) instacron:SBCCV |
instname_str |
Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV) |
instacron_str |
SBCCV |
institution |
SBCCV |
reponame_str |
Brazilian Journal of Cardiovascular Surgery (Online) |
collection |
Brazilian Journal of Cardiovascular Surgery (Online) |
repository.name.fl_str_mv |
Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV) |
repository.mail.fl_str_mv |
||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br |
_version_ |
1752126599885488128 |